Abstract
Methylmalonic acidemia (MMA) is an inborn error of organic acid metabolism. Patients with severe disease develop many complications despite treatment; often, the disease progresses to severe damage of the central nervous system or to end-stage renal disease (ESRD). When medical treatment is ineffective, liver, kidney, or combined liver and kidney transplantation is advocated. At present, there are no definite guidelines as for the organ to be transplanted, and results are inconsistent. We report on a 27-year-old woman with MMA MUT0. The clinical symptoms developed at age 4 months. She progressed to ESRD and received a kidney transplant in November 1996 at age 17 years. One hundred and twenty months after transplant, renal function is normal; although urinary levels of methylmalonic acid are above normal limits, no episodes of metabolic decompensation have been observed after transplantation. Although liver is the major site of methylmalonyl-CoA mutase activity, this case and similar ones in the literature suggest that the smaller mutase activity present in the transplanted kidney may be sufficient to ensure partial correction of the metabolism of organic acids sufficient to prevent the onset of episodes of metabolic decompensation. It is worth investigating whether kidney transplant can be a safer and more satisfactory alternative to liver transplantation in cases of MMA unresponsive to medical treatment although urine MMA excretion remains significantly elevated.
References
Scriver CR, Beaudet AL, Sly WS, Valle D (2001) The metabolic and molecular basics of inherited disease, 8th edn. McGraw-Hill, New York, pp 1423–1449
de Baulny H, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM (2005) Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis 28:415–423
Prietsch V, Lindner M, Zschocke J, Nyhan WL, Hoffmann GF (2002) Emergency management of inherited metabolic diseases. J Inherit Metab Dis 25:531–546
Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E (1999) Dilalysis in neonate with inborn errors of metabolism. Nephrol Dial Transplant 14:910–918
Paik KH, Lee JE, Jin DK (2004) Successful dialysis in a boy with methylmalonic acidemia. Pediatr Nephrol 19:1180–1181
Meer SB, van der Poggi F, Spada M, Bonnenfort JP, Ogier H, Hubert P, Depondt E, Rappaport D, Rabier D, Charpentier C (1994) Clinical outcome of long term management of patients with vitamin B12-unresponsive methylmalonic acidemia. J Pediatr 125:903–908
Nicolaides P, Leonard JV, Surtees R (1998) The neurological outcome of methylmalonic acidemia. Arch Dis Child 78:508–512
Baumgartner ER, Viardot C (1995) Long term follow-up of 77 patients with isolated methylmalonic aciduria. J Inherit Metab Dis 18:138–142
Tanpaiboon P (2005) Methylmalonic acidemia (MMA). Mol Genet Metab 85:2–6
De Souza C, Peisowicz AT, Brett EM, Leonard JV (1989) Focal changes in the globi pallidi associated with neurological dysfunction in methylmalonic acideamia. Neuropediatrics 20:199–201
Leonard JV (1995) The management and outcome of propionic and methylmalonic acidemias. J Inherit Metab Dis 18:430–434
Rutledge SL, Geraghty M, Mroczek E, Rosenblatt D, Kohout E (1993) Tubolointerstitial nephritis in methylmalonic acidemia. Pediatr Nephrol 7:81–82
D’Angio CT, Dillon MJ, Leonard JV (1991) Renal tubular dysfunction in methylmalonic acidaemia. Eur J Pediatr 150:259–263
Walther JH, Michalski A, Wilson WM, Leonard JV, Barratt TM, Dillon MJ (1989) Chronic renal failure in methylmalonic acidaemia. Eur J Pediatr 148:344–348
Molteni KH, Oberley TD, Wolff JA, Friedman AL (1991) Progressive renal insufficiency in methylmalonic acidemia. Pediatr Nephrol 5:323–326
Horster F, Hoffmann GF (2004) Pathophysiology, diagnosis and treatment of methylmalonic aciduria–recent advances and new challenges. Pediatr Nephrol 19:1071–1074
Schmitt CP, Mehls O, Trefz FK, Horster F, Weber TL, Koller S (2004) Reversible end-stage renal disease in an adolescent patient with methylmalonic aciduria. Pediatr Nephrol 19:1182–1184
Van’t Hoff W, McKiernan PJ, Surtees RAH, Leonard JV (1999) Liver transplantation for methylmalonic acidemia. Eur J Pediatr 158:S70–S74
Meyburg J, Hoffmann GF (2005) Liver transplantation for inborn errors of metabolism. Transplantation 80:S135–S137
Lubrano R, Scoppi P, Travasso E, Scateni S, Cristaldi S, Castello MA (2001) Kidney transplantation in a girl with methylmalonic acidemia and end stage renal failure. Pediatr Nephrol 16:848–851
Giorgio AJ, Plaut GWE (1965) A method for the colorimetric determination of urinary MMA in pernicious anemia. J Lab Clin Med 66:667–676
Heindreich R, Natowicz M, Hainline BE, Berman P, Kelli RI, Hillman RE, Berry GT (1988) Acute extrapyramidal syndrome in methylmalonic acidemia: “ metabolic stroke” involving the globus pallidus. J Pediatr 113:1022–1027
Hass RH, Marsden DL, Capistrano-Estrada S, Hamilton R, Grafe MR, Wong W, Nyhan WL (1995) Acute basal ganglia infarction in propionic acidemia. J Child Neurol 10:18–22
Davidson AN, Thompson RHS (1981) The molecular basis of neuropathology. Edward Arnold Limited, London, pp 104–131
Kolker S, Schwab M, Horster F, Sauer S, Hinz A, Wolf NI, Mayatepek E, Hoffmann GF, Smeitink JAM, Okun JG (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278:47388–47393
Pettenuzzo LF, Ferreira GC, Schmidt AL, Dutra-Filho CS, Wyse ATS, Wajner M (2006) Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues. Int J Dev Neuroscience 24:45–52
Rotig A, Goutieres F, Niaudet P, Rustin P, Chretien D, Guest G, Mikol J, Gubler MC, Munnich A (1995) Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr 126:567–601
Buemi M, Allegra A, Rotig A, Gubler MC, Aloisis C, Corica F, Pettinato G, Frisina N, Niaudet P (1997) Renal failure from mitochondrial cytopathies. Nephron 76:249–253
Kashtan CE, Abousedira M, Rozen S, Manivel JC, McCann M, Tuchman M (1998) Chronich administration of methylmalonic acid (MMA) to rats causes proteinuria and renal tubular injury. Pediatr Res 43:309A
Chakrapani A, Sivakumar P, McKiernan PL, Leonard JV (2002) Metabolic stroke in methylmalonic acidemia five years after liver transplantation. J Pediatr 140:261–263
Nyhan WL, Gargus JJ, Boyle K, Selby R, Koch R (2002) Progressive neurological disability in methylmalonic acidemia despite transplantation of the liver. Eur J Pediatr 161:377–379
Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, Turcotte JG, Campbell DA Jr, Holmes R, Magee JC (2002) Long term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 6:295–300
Hsui JY, Chein YH, Chu SY, Lu FL, Chen HL, Ho MJ, Lee PH, Hwu WL (2003) Living-related liver transplantation for methylmalonic academia: report of one case. Acta Paediatr Taiwan 44:171–173
Huang HP, Chien YH, Huang LM, Ni YH, Chang MH, Ho MC, Lee PH, Hwu WL (2005) Viral infection and prolonged fever after liver transplantation in young children with inborn errors of metabolism. J Formos Med Assoc 104:623–629
Morioka D, Kasahara M, Takada Y, Corrales JP, Yoshizawa A, Sakamoto S, Taira K, Yoshitoshi EY, Egawa H, Shimada H, Tanaka K (2005) Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant 5:2754–2763
Kasahara M, Horikawa R, Tagawa M, Uemoto S, Yokoyama S, Shibata YT, Kawano T, Kuroda T, Honna T, Tanaka K, Saeki M (2006) Current role of liver transplantation for methylmalonic acidemia: a review of the literature. Pediatr Transplant 10:943–947
Kaplan P, Ficicioglu C, Mazur AT, Palmieri MJ, Berry GT (2006) Liver transplantation is not curative for methylmalonic acidopathy caused by methylmalonyl-CoA mutase deficiency. Mol Genet Metab 88:322–326
Van’t Hoff WG, McKiernan PJ, Surtees RA, Leonard JV (1998) Combined liver-kidney transplantation in methylmalonic acidemia. J Pediatr 132:1043–1044
Nagarajan S, Enns GM, Millan MT, Winter S, Sarwal MM (2005) Management of methylmalonic acidaema by combined liver-kidney transplantation. J Inherit Metab Dis 28:517–524
Coman D, Huang J, McTaggart S, Sakamoto O, Ohura T, McGill J, Burke J (2006) Renal transplantation in a 14-year-old girl with vitamin B12-responsive cnIA-type methylmalonic acidaemia. Pediatr Nephrol 21:270–273
Van Calcar SC, Harding CO, Lyne P, Hogan K, Banerjee R, Sollinger H, Rieselbach RE, Wolff JA (1998) Renal transplantation in a patient with methylmalonic acidaemia. J Inher Metab Dis 21:729–737
Andrews E, Jansen R, Crane AM, Cholin S, McDonnel D, Ledley F (1993) Expression of recombinant human methylmalonyl CoA mutase: in primary mut fibroblasts and Saccharomyces cerevisiae. Biochem Med Metab Biol 50:135–144
Magera MJ, Helgeson JK, Matern D, Rinaldo P (2000) Methylmalonic acid measured in plasma and urine by stable-isotope dilution and electrospray tandem mass spectrometry. Clin Chem 46:1804–1810
Author information
Authors and Affiliations
Corresponding author
Additional information
Source of financial support
The study was made possible by an unrestricted grant from nuovArmonia nonprofit organization.
Rights and permissions
About this article
Cite this article
Lubrano, R., Elli, M., Rossi, M. et al. Renal transplant in methylmalonic acidemia: could it be the best option?. Pediatr Nephrol 22, 1209–1214 (2007). https://doi.org/10.1007/s00467-007-0460-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0460-z